Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
 Moves Forward With Uplifting Requirements for OTCQB, Aggressively Pursues Take Over Targets - EconoTimes)
VIRGINIA BEACH, Va., Oct. 18, 2017 -- BioForce Nanosciences Holdings, Inc. (OTCPINK:BFNH) announces its pursuit to uplift the Company’s tradable common shares onto the OTCQB at OTCMARKETS.COM.
The Company hired new accountants, PCAOB auditors and a securities law firm to assist on the necessary financial disclosures and other related requirements for uplift, OTCQB.
During the last few quarters of operations, BFNH’s management team aggressively looked at a number of unique businesses operations with acquisition intentions. Due diligence continues on these acquisition “targets” and management believes at least one or more can be acquired.
BFNH management looks at the each target with specific comprehensible modeling, not just limited to goods and services, but includes competition, patents, domestic/international demographics, demand of products/services, outstanding debts/liabilities and other business transparencies.
BFNH will provide more information as the deal-flow becomes more mature.
For further information about this release, contact YES INTERNATIONAL, Investor Relations, 757-306-6090, [email protected] and www.yesinternational.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competitions.
CONTACT: BioForce Nanosciences Holdings, Inc.
Rich Kaiser, 757-306-6090
